Author:
Inzaule Seth C,Hamers Raph L,Doherty Meg,Shafer Robert W,Bertagnolio Silvia,Rinke de Wit Tobias F
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Switch to fixed-dose ainuovirine, lamivudine, and tenofovir DF versus elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed people living with HIV-1: the 48-week results of the SPRINT trial, a multi-centre, randomised, double-blind, active-controlled, phase 3, non-inferiority trial;The Lancet Regional Health - Western Pacific;2024-08
2. Resistance-informed versus empirical management of viraemia in children and adolescents with HIV in Lesotho and Tanzania (GIVE MOVE trial): a multisite, open-label randomised controlled trial;The Lancet Global Health;2024-08
3. The rollout of paediatric dolutegravir and virological outcomes among children living with HIV in Mozambique;Southern African Journal of HIV Medicine;2024-07-31
4. HIV-1 diversity and pre-treatment drug resistance in the era of integrase inhibitor among newly diagnosed ART-naïve adult patients in Luanda, Angola;Scientific Reports;2024-07-10
5. The impact of the COVID-19 pandemic on people living with HIV: a cross-sectional study in Caracas, Venezuela;BMC Infectious Diseases;2024-01-15